[Research Progress of Circular RNAs in Tumor Immunotherapy]. [PDF]
Zhongguo Fei Ai Za Zhi, 2021 Zhang C, Peng L, Ji J, Jiao W.
europepmc +1 more source
[Advances in the study of cellular immunotherapy for liver cancer]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Su S, Huang XW.
europepmc +1 more source
[Researche advances on CIK cells and their clinical use in lung cancer]. [PDF]
Zhongguo Fei Ai Za Zhi, 2011 Luo H, Zhou X.
europepmc +1 more source
[Research Progress of Immunotherapy and Prognostic Markers in Small Cell Lung Cancer]. [PDF]
Zhongguo Fei Ai Za Zhi, 2020 Wang Q, Peng W, Jiang M, Wu L.
europepmc +1 more source
[Strategies and challenges of immunotherapy for hepatocellular carcinoma]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Zhang HH, Chen HS.
europepmc +1 more source
[Research progress of immunotherapy alone and in combination for liver cancer]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2020 Wu ZJL, Li K, Zhang K, Gong WD.
europepmc +1 more source
[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer]. [PDF]
Zhongguo Fei Ai Za Zhi, 2020 Guo H, Bai R, Cui J.
europepmc +1 more source
[Progress and prospects of clinical cell therapy for liver cirrhosis and liver cancer]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2019 Liu K, Wang LF, Wang FS, Shi M.
europepmc +1 more source
[Biological characteristics and antitumor activity of CIK cells activated by recombinant human fibronectin for human lung cancer cell lines in vitro]. [PDF]
Zhongguo Fei Ai Za Zhi, 2010 Wang S +9 more
europepmc +1 more source
[Mechanism of NKG2D ligands-mediated immune escape of adriamycin resistant leukemia K562/A02 cells]. [PDF]
Zhonghua Xue Ye Xue Za Zhi, 2018 Jia ZX +8 more
europepmc +1 more source